Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Niraparib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 13,930Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Belmore Neidrauer LLP

    02 8GlaxoSmithKline Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Belmore Neidrauer LLP

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE
    arrow
    ASPEN
    Not Confirmed

    Belmore Neidrauer LLP

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2027-04-02

    Date Granted : 2016-02-23

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE

    Brand Name : AKEEGA

    Patent Number : 2647545

    Filing Date : 2007-04-02

    Strength per Unit : 50mg / 500mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2027-04-02

    Date Granted : 2016-02-23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Belmore Neidrauer LLP

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE
    arrow
    ASPEN
    Not Confirmed

    Belmore Neidrauer LLP

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2028-01-08

    Date Granted : 2012-07-17

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE

    Brand Name : AKEEGA

    Patent Number : 2674436

    Filing Date : 2008-01-08

    Strength per Unit : 50mg / 500mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2028-01-08

    Date Granted : 2012-07-17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Belmore Neidrauer LLP

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE
    arrow
    ASPEN
    Not Confirmed

    Belmore Neidrauer LLP

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2029-01-08

    Date Granted : 2016-03-08

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE

    Brand Name : AKEEGA

    Patent Number : 2711491

    Filing Date : 2009-01-08

    Strength per Unit : 50mg / 500mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2029-01-08

    Date Granted : 2016-03-08

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Belmore Neidrauer LLP

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE
    arrow
    ASPEN
    Not Confirmed

    Belmore Neidrauer LLP

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2027-04-02

    Date Granted : 2016-02-23

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE

    Brand Name : AKEEGA

    Patent Number : 2647545

    Filing Date : 2007-04-02

    Strength per Unit : 100mg / 500mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2027-04-02

    Date Granted : 2016-02-23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Belmore Neidrauer LLP

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE
    arrow
    ASPEN
    Not Confirmed

    Belmore Neidrauer LLP

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2028-01-08

    Date Granted : 2012-07-17

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE

    Brand Name : AKEEGA

    Patent Number : 2674436

    Filing Date : 2008-01-08

    Strength per Unit : 100mg / 500mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2028-01-08

    Date Granted : 2012-07-17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Belmore Neidrauer LLP

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE
    arrow
    ASPEN
    Not Confirmed

    Belmore Neidrauer LLP

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2029-01-08

    Date Granted : 2016-03-08

    NIRAPARIB TOSYLATE, ABIRATERONE ACETATE

    Brand Name : AKEEGA

    Patent Number : 2711491

    Filing Date : 2009-01-08

    Strength per Unit : 100mg / 500mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2029-01-08

    Date Granted : 2016-03-08

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    GlaxoSmithKline Inc.

    NIRAPARIB TOSYLATE
    arrow
    ASPEN
    Not Confirmed

    GlaxoSmithKline Inc.

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2027-04-02

    Date Granted : 2016-02-23

    NIRAPARIB TOSYLATE

    Brand Name : ZEJULA

    Patent Number : 2647545

    Filing Date : 2007-04-02

    Strength per Unit : 100 mg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2027-04-02

    Date Granted : 2016-02-23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    GlaxoSmithKline Inc.

    NIRAPARIB TOSYLATE
    arrow
    ASPEN
    Not Confirmed

    GlaxoSmithKline Inc.

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2028-01-08

    Date Granted : 2012-07-17

    NIRAPARIB TOSYLATE

    Brand Name : ZEJULA

    Patent Number : 2674436

    Filing Date : 2008-01-08

    Strength per Unit : 100 mg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2028-01-08

    Date Granted : 2012-07-17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    GlaxoSmithKline Inc.

    NIRAPARIB TOSYLATE
    arrow
    ASPEN
    Not Confirmed

    GlaxoSmithKline Inc.

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2029-01-08

    Date Granted : 2016-03-08

    NIRAPARIB TOSYLATE

    Brand Name : ZEJULA

    Patent Number : 2711491

    Filing Date : 2009-01-08

    Strength per Unit : 100 mg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2029-01-08

    Date Granted : 2016-03-08

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    GlaxoSmithKline Inc.

    NIRAPARIB TOSYLATE
    arrow
    ASPEN
    Not Confirmed

    GlaxoSmithKline Inc.

    Country
    arrow
    ASPEN
    Not Confirmed

    Patent Expiration Date : 2037-06-29

    Date Granted : 2023-08-15

    NIRAPARIB TOSYLATE

    Brand Name : ZEJULA

    Patent Number : 3029671

    Filing Date : 2017-06-29

    Strength per Unit : 100 mg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2037-06-29

    Date Granted : 2023-08-15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.